These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7435225)

  • 21. The toxicity of non-ionic water-soluble monomeric and dimeric contrast media in selective vertebral angiography. An experimental study in rabbits.
    Skalpe IO
    Neuroradiology; 1983; 24(4):219-23. PubMed ID: 6828238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuroradiological experiences iopamidol, a new non-ionic hydro-soluble contrast medium. Comparison to metrizamide with special considerations of side effects and pharmacodynamics with regard to clinical use (author's transl)].
    Hammer B
    Radiologe; 1981 Jun; 21(6):274-81. PubMed ID: 6973775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical comparison of metrizamide and iopamidol for myelography.
    Turski PA; Sackett JF; Gentry LR; Strother CM; Matozzi F
    AJNR Am J Neuroradiol; 1983; 4(3):309-11. PubMed ID: 6410729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteinuria following nephroangiography. IX. Chemical and morphological analysis in dogs.
    Holtås S; Billström A; Tejler L
    Acta Radiol Diagn (Stockh); 1981; 22(4):427-33. PubMed ID: 6174021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Iopamidol in renal arteriography].
    Kasbarian M; Pinot JJ; Casal P; Bouscarle B
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):726-8. PubMed ID: 6670830
    [No Abstract]   [Full Text] [Related]  

  • 26. Visual evoked response changes following intrathecal injection of water-soluble contrast media: a possible method of assessing neurotoxicity and a comparison of metrizamide and iopamidol.
    Broadbridge AT; Bayliss SG; Firth R; Farrell G
    Clin Radiol; 1984 Sep; 35(5):371-3. PubMed ID: 6547888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The risk of arachnoiditis from experimental nonionic contrast media.
    Haughton VM; Ho KC
    Radiology; 1980 Aug; 136(2):395-7. PubMed ID: 6773100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Side effects of 2 water-soluble contrast media used in myelography].
    Caillé JM
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):779-82. PubMed ID: 6689467
    [No Abstract]   [Full Text] [Related]  

  • 29. An assessment of iopamidol, a non-ionic contrast medium, in aorto-femoral angiography.
    Whitehouse GH; Snowdon SL
    Clin Radiol; 1982 Mar; 33(2):231-4. PubMed ID: 7067356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of contrast media on aortic endothelium. Experiments in the rat with non-ionic monomeric and monoacidic dimeric contrast media.
    Nyman U; Almén T
    Acta Radiol Suppl; 1980; 362():65-71. PubMed ID: 6168170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of iopamidol with three other contrast media in orbital venography/cavernous sinography.
    Macpherson P
    Br J Radiol; 1982 Jul; 55(655):539-40. PubMed ID: 7150905
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experimental and clinical determination of renal size after intravenous and intra-arterial administration of ionic and non-ionic contrast media].
    Helzel MV; Wolf GK; Prager P
    Rofo; 1985 Mar; 142(3):333-7. PubMed ID: 2984739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myelography with lopamidol.
    Lamb JT; Holland IM
    AJNR Am J Neuroradiol; 1983; 4(3):851-3. PubMed ID: 6410871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurotoxicologic effects of the nonionic contrast agent iopamidol on the leptomeninges of the dog.
    Spencer CP; Chrisman CL; Mayhew IG; Kaude JV
    Am J Vet Res; 1982 Nov; 43(11):1958-62. PubMed ID: 6891192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safer, more expensive iodinated contrast agents: how do we decide?
    Wolf GL
    Radiology; 1986 May; 159(2):557-8. PubMed ID: 3961192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of iopamidol with metrizamide in sub-occipital ventriculography/cisternography.
    Macpherson P; Teasdale E
    Br J Radiol; 1982 Jul; 55(655):540-1. PubMed ID: 6983902
    [No Abstract]   [Full Text] [Related]  

  • 37. Autoradiographic method for quantitative evaluation of the blood-brain barrier effects of contrast media.
    Gregoire N; Nezri C; Gazendam J; Vial M; Salamon G
    AJNR Am J Neuroradiol; 1983; 4(3):323-5. PubMed ID: 6410734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized blind trial of iopamidol (Niopam) and Metrizamide (Amipaque) in lumber radiculography.
    McAllister VL; Hall K
    Neuroradiology; 1983; 24(4):217-8. PubMed ID: 6338415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advantages of non-ionic contrast media in vascular applications.
    Malott JC; Fodor J
    Radiol Technol; 1984; 56(2):95-8. PubMed ID: 6390518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteinuria following nephroangiography. VIII. Comparison between diatrizoate and iohexol in the rat.
    Holtås S; Golman K; Törnquist C
    Acta Radiol Suppl; 1980; 362():53-5. PubMed ID: 6267894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.